The efficacy and safety of daunorubicin versus idarubicin combined with cytarabine for induction therapy in acute myeloid leukemia: A meta-analysis of randomized clinical trials

OBJECTIVE: To ascertain the efficacy and safety of daunorubicin combined with cytarabine comparing with idarubicin combined with cytarabine as a standard induction therapy for acute Myeloid leukemia by a meta-analysis. METHODS: The randomized controlled trials included were retrieved from PubMed, Em...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hanyu, Xiao, Xueting, Xiao, Qirong, Lu, Yanhong, Wu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302600/
https://www.ncbi.nlm.nih.gov/pubmed/32541448
http://dx.doi.org/10.1097/MD.0000000000020094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302600/
https://www.ncbi.nlm.nih.gov/pubmed/32541448
http://dx.doi.org/10.1097/MD.0000000000020094

Ejemplares similares